# Association between body roundness index and reproductive outcomes in patients with polycystic ovary syndrome: a secondary analysis based on PCOSAct

**Authors:** Jiannan Yu, Hang Ge, Zhuwei Gao, Jiaxing Feng, Yue Gao, Jing Cong, Mengyi Zhu, Baichao Shi, Muxin Guan, Jingshu Gao, Xiaoke Wu

PMC · DOI: 10.3389/fnut.2026.1705555 · Frontiers in Nutrition · 2026-02-05

## TL;DR

Higher body roundness index is linked to worse reproductive outcomes in women with polycystic ovary syndrome, suggesting it could help assess fertility risks.

## Contribution

This study is the first to examine the nonlinear relationship between body roundness index and reproductive outcomes in PCOS patients.

## Key findings

- Higher BRI quartiles were associated with worse anthropometric, metabolic, and hormonal profiles at baseline.
- Nonlinear associations were found between BRI and clinical pregnancy and live birth outcomes.
- BRI showed significant trends with lower odds of reproductive outcomes across quartiles after adjustment.

## Abstract

Obesity, especially visceral obesity, is highly prevalent in women with polycystic ovary syndrome (PCOS) and may adversely affect fertility outcomes. Body roundness index (BRI) is an anthropometric indicator of visceral adiposity, yet evidence linking BRI to key reproductive outcomes remains limited in PCOS.

This secondary analysis included 998 Chinese women from the Polycystic Ovary Syndrome Acupuncture and Clomiphene Trial (PCOSAct). Baseline BRI was calculated from waist circumference and height measurements, and reproductive outcomes were obtained after interventions. Baseline BRI was calculated from height, weight, and waist circumference and analyzed as quartiles (Q1: < 2.97, Q2: 2.97–3.78, Q3: 3.78–4.87, Q4: ≥ 4.87) and as a continuous variable. Logistic regression models estimated odds ratios (ORs) and 95% confidence intervals (CIs) for ovulation, conception, clinical pregnancy, and live birth, adjusting for interventions, age, systolic and diastolic blood pressure (SBP and DBP). Nonlinearity was assessed using restricted cubic splines (RCS), with model fit compared against linear models using likelihood ratio tests.

In total, 780 participants regained ovulation, 320 achieved conception, 218 attained clinical pregnancy, and 205 had a live birth. Higher BRI quartiles were associated with worse anthropometric, metabolic, and hormonal profiles at baseline. In regression analyses, higher BRI quartiles were generally associated with lower odds of reproductive outcomes, with significant trends across quartiles after adjustment. Restricted cubic spline analyses showed no evidence of nonlinearity for ovulation or conception (P-nonlinear = 0.951 and 0.301), but significant nonlinearity for clinical pregnancy and live birth (P-nonlinear = 0.016 and 0.025).

Higher BRI was associated with poorer reproductive outcomes in women with PCOS, with evidence of nonlinear associations for clinical pregnancy and live birth. BRI may provide clinically relevant information beyond general adiposity for reproductive risk stratification in PCOS.

## Linked entities

- **Diseases:** polycystic ovary syndrome (MONDO:0008487)

## Full-text entities

- **Genes:** SHBG (sex hormone binding globulin) [NCBI Gene 6462] {aka ABP, SBP, TEBG}, APOB (apolipoprotein B) [NCBI Gene 338] {aka FCHL2, FLDB, LDLCQ4, apoB-100, apoB-48}, INS (insulin) [NCBI Gene 3630] {aka IDDM, IDDM1, IDDM2, ILPR, IRDN, MODY10}, APOA1 (apolipoprotein A1) [NCBI Gene 335] {aka AMYLD3, HPALP2, apo(a)}
- **Diseases:** IVF (MESH:C566179), visceral adiposity (MESH:D007418), abdominal obesity (MESH:D056128), reproductive dysfunction (MESH:D060737), metabolic (MESH:D008659), acanthosis nigricans (MESH:D000052), acne (MESH:D000152), FG (MESH:C537923), overweight (MESH:D050177), type 2 diabetes (MESH:D003924), miscarriage (MESH:D000022), adiposity (MESH:D018205), Obesity (MESH:D009765), depression (MESH:D003866), prediabetes (MESH:D011236), weight loss (MESH:D015431), IR (MESH:D007333), BRI (MESH:D018208), nonalcoholic fatty liver disease (MESH:D065626), cardiovascular disease (MESH:D002318), infertility (MESH:D007246), endocrine disorders (MESH:D004700), PCOS (MESH:D011085), female infertility (MESH:D007247), anovulation (MESH:D000858), Hirsutism (MESH:D006628), inflammation (MESH:D007249), cardiometabolic multimorbidity (MESH:D024821)
- **Chemicals:** glucose (MESH:D005947), cholesterol (MESH:D002784), Glycolipid (MESH:D006017), progesterone (MESH:D011374), testosterone (MESH:D013739), TG (MESH:D014280), Clomiphene (MESH:D002996), E2 (MESH:D004958), P (MESH:D010758), BRI (-), T (MESH:D014316)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12916401/full.md

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC12916401/full.md

## References

46 references — full list in the complete paper: https://tomesphere.com/paper/PMC12916401/full.md

---
Source: https://tomesphere.com/paper/PMC12916401